| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/28/1990 | EP0355202A1 Factor regulating gene expression |
| 02/28/1990 | EP0355190A1 Factor regulating gene expression |
| 02/28/1990 | EP0355142A1 Site-specific homogeneous modification of polypeptides to facilitate covalent linkages to a hydrophilic moiety |
| 02/28/1990 | EP0355140A1 Human monoclonal anti-hiv-i-antibodies |
| 02/28/1990 | EP0355097A1 Substituted cyclic complex-forming substances, complexes and complex salts, process for manufacturing same, and pharmaceutical agents which contain them |
| 02/28/1990 | EP0355093A1 Human interleukin-3 and muteins thereof |
| 02/28/1990 | EP0143850B1 Novel physiologically active proteinaceous substance |
| 02/28/1990 | CN1040054A Compound having biological activity, and preparing process therefor |
| 02/28/1990 | CN1040053A Expression of hepatitis b pres2 protein in methylotrophic yeasts |
| 02/28/1990 | CN1040052A Kluyveromyces as host strain |
| 02/28/1990 | CN1040033A Amphiphilic peptides and use thereof |
| 02/27/1990 | US4904763 Physiologically-active novel peptides |
| 02/27/1990 | US4904643 Immunology |
| 02/27/1990 | US4904642 Therapeutic somatostatin analogs |
| 02/27/1990 | US4904602 Thioredoxin shufflease and use thereof |
| 02/27/1990 | US4904596 Medical diagnosis |
| 02/27/1990 | US4904584 Erythropoietin or a colony stimulating factor having lysine replacements and at least one polyoxyalkylene glycol moiety; solubility; pharmacokinetics |
| 02/22/1990 | WO1990001556A1 In vivo infection of live insects with a recombinant baculovirus |
| 02/22/1990 | WO1990001551A1 Producing commercially valuable polypeptides with genetically transformed endosperm tissue |
| 02/22/1990 | WO1990001549A2 Gene encoding protein antigens of plasmodium falciparum |
| 02/22/1990 | WO1990001547A1 Methods for isolating herpes virus thymidine kinase-encoding dna |
| 02/22/1990 | WO1990001546A1 Equine herpesvirus-1 vaccine |
| 02/22/1990 | WO1990001543A1 Method for the genetic expression of heterologous proteins by cells transfected in vivo |
| 02/22/1990 | WO1990001540A1 Method for stabilizing heterologous protein expression and vectors for use therein |
| 02/22/1990 | WO1990001497A1 IMMUNOGENIC GLYCOPROTEINS OF HUMAN CYTOMEGALOVIRUS gCII |
| 02/22/1990 | WO1990001496A1 Polypeptides and dna encoding same |
| 02/22/1990 | WO1990001495A1 Synthetic polypeptides and antibodies related to epstein-barr virus nuclear antigen |
| 02/22/1990 | WO1990001494A1 Polypeptide pertussis toxin vaccine |
| 02/22/1990 | WO1990001338A1 Leukocyte adhesion inhibitor |
| 02/22/1990 | WO1990001336A1 Novel infectious bursal disease virus |
| 02/22/1990 | WO1990001261A1 Overexpression of phytochrome in transgenic plants |
| 02/22/1990 | WO1988007551A3 Growth factor receptor |
| 02/21/1990 | EP0355065A1 Renin inhibitory peptides containing suleptanic acid or derivatives thereof |
| 02/21/1990 | EP0355047A1 Purified protein A compositions and methods for their preparation |
| 02/21/1990 | EP0355039A2 Methods and means for controlling the stability of proteins |
| 02/21/1990 | EP0354992A2 Conjugates of VIP and active fragments thereof with hydrophobic moieties and topical compositions for use in the treatment of male impotence |
| 02/21/1990 | EP0354989A1 Megakaryocytopoietin, preparation and use |
| 02/21/1990 | EP0354934A1 Neutrophil-activating polypeptide, process for its manufacture and its use as a drug and diagnosticum |
| 02/21/1990 | CN1039843A Process for producing hegf |
| 02/21/1990 | CN1006903B Production method for interleukin-2 |
| 02/20/1990 | US4902783 Adsorption with silica gel, adsorption with activated carbon, density gradient centrifuging and equilibrium density gradient centrifuging |
| 02/20/1990 | US4902782 Isolation of fibroblast growth factor |
| 02/20/1990 | US4902618 Production of hybridoma antibodies for interferon |
| 02/20/1990 | US4902615 Diagnostic kit for cancer |
| 02/20/1990 | US4902509 Process for the isolation of chicken egg cystatin, antiviral agents containing it and its use as viral protease inhibitor |
| 02/20/1990 | US4902506 Immunogenic conjugates |
| 02/20/1990 | US4902505 Chimeric peptides for neuropeptide delivery through the blood-brain barrier |
| 02/20/1990 | US4902500 Polyoxypropylene-polyoxyethylene block polymer and phospholipid |
| 02/14/1990 | EP0354729A2 Cytotoxic drug conjugates |
| 02/14/1990 | EP0354728A2 Cytotoxic drug conjugates |
| 02/14/1990 | EP0354687A1 Overexpression of phytochrome in transgenic plants |
| 02/14/1990 | EP0354624A2 A method for identifying and using biosynthetic or regulatory genes for enhanced production of secondary metabolites |
| 02/14/1990 | EP0354611A1 Synthtic antigens useful in the diagnosis of malaria induced by plasmodium vivax |
| 02/14/1990 | EP0354592A1 A novel human physiologically active polypeptide |
| 02/14/1990 | EP0354580A2 HLA class I DNA, DNA probes and transformed cells |
| 02/14/1990 | EP0354522A1 Use of alpha-aminoboronic acid derivatives in prevention and treatement of viral diseases |
| 02/14/1990 | EP0354507A2 Process for producing des-B30 insulins and derivatives thereof |
| 02/14/1990 | EP0354492A2 Preparing process of physiologically active substance with anticancer effect and substance obtained thereby |
| 02/14/1990 | EP0354440A1 Human Papilloma virus type 57, its DNA and proteins encoded thereby |
| 02/14/1990 | EP0354354A2 Process for concentrating blood coagulation factors II, VII, IX en X |
| 02/14/1990 | EP0354213A1 Transgenic animal cells resistant to viral infection |
| 02/14/1990 | CN1039616A Pichia pastoris alcohol oxidase ii regulatory region |
| 02/14/1990 | CN1039597A Neurokinin a antagonists |
| 02/14/1990 | CN1039596A Retroviral protease binding peptides |
| 02/14/1990 | CN1006808B Purification of lipotropic protein produced by pichia yeast |
| 02/13/1990 | US4900837 Brain-specific drug delivery of steroid sex hormones cleaved from pyridinium carboxylates and dihydro-pyridine carboxylate precursors |
| 02/13/1990 | US4900816 Hemoglobin complexes |
| 02/13/1990 | US4900811 Synthetic polypeptides corresponding to portions of proteinoids translated from brain-specific mRNAs, receptors, methods and diagnostics using the same |
| 02/13/1990 | US4900780 Acellular resuscitative fluid |
| 02/13/1990 | US4900747 Method and agents for removing advanced glycosylation endproducts |
| 02/13/1990 | US4900719 Nitrosothiols as hypotensive agents |
| 02/13/1990 | US4900686 Fluorescent conjugates and biological diagnostic assay |
| 02/13/1990 | US4900673 Mutant human angiogenin (angiogenesis factor with superior angiogenin activity) genes therefor and methods of expression |
| 02/13/1990 | US4900662 CK-MM myocardial infarction immunoassay |
| 02/13/1990 | US4900661 Method for immunological determination of amines, monoclonal antibodies and kit of reagents for carrying out the method |
| 02/13/1990 | US4900660 Streptococcal fc rc |
| 02/13/1990 | US4900659 Nucleotide sequence composition and method for detection of Neisseria gonorrhoeae and method for screening for a nucleotide sequence that is specific for a genetically distinct group |
| 02/13/1990 | US4900547 Method to immunize mammals against tumors |
| 02/13/1990 | CA1265900A1 Peptides aiding nerve regeneration |
| 02/13/1990 | CA1265899A1 Peptides and their use in therapy |
| 02/08/1990 | WO1990001066A1 Porcine polyclonal and monoclonal antibodies |
| 02/08/1990 | WO1990001063A1 New secretory leader sequences |
| 02/08/1990 | WO1990001061A1 In vitro synthesis of an infectious rna |
| 02/08/1990 | WO1990001039A1 Nonglycosylated human interleukin-3 compositions |
| 02/08/1990 | WO1990001038A1 Human insulin analogs and preparations containing them |
| 02/08/1990 | WO1990001035A1 Cytotoxic agent against specific virus infection |
| 02/08/1990 | WO1990000901A1 Synthetic vaccine against aids virus |
| 02/08/1990 | WO1989009788A3 Biosynthetic osteogenic proteins and osteogenic devices containing them |
| 02/08/1990 | WO1989009787A3 Osteogenic devices |
| 02/08/1990 | DE3825189A1 In vitro synthesis of an infectious RNA of HRV2 |
| 02/07/1990 | EP0354109A1 Recombinant HBsAg hybrid particles having morphological characteristics of the HBsAg antigen and containing an immunogenic sequence which induces neutralizing antibodies directed against HIV or susceptible of being recognized by such antibodies. Nucleotide sequences coding for such particles and vaccines containing them |
| 02/07/1990 | EP0354108A1 Amino acids and peptides with a modified tyrosine, their preparation and their use as medicines |
| 02/07/1990 | EP0354072A1 Precursors of the HIV-2 retrovirus envelope glycoprotein and related antigens |
| 02/07/1990 | EP0353910A2 Human interferon-gamma, process for preparing said human interferon-gamma, and its use |
| 02/07/1990 | EP0353908A2 DNA constructs and plant incorporating them |
| 02/07/1990 | EP0353861A1 Angiogenesis inhibitor |
| 02/07/1990 | EP0353851A1 Fowlpox virus non-essential regions |
| 02/07/1990 | EP0353814A2 Synthetic peptide endowed with immunological activity, capable of inducing the production of antibodies with a high specificity towards alpha-fetoprotein, and their use in the diagnostic field |
| 02/07/1990 | EP0353809A1 Pseudorabies virus vaccine |
| 02/07/1990 | EP0353780A2 Factor for the activation of target cells |